Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Obesity management entered a decisive new phase in 2026. Three unique receptor agonist therapies currently populate the weight management formulary. These modern options include semaglutide injection, tirzepatide injection, and orforglipron tablets. Each agent, consequently, employs a distinct molecular strategy to…
Managing your weight is rarely a simple journey. For years, patients and doctors have navigated complicated treatment plans. Often, these plans yielded mixed long-term results. Recently, a class of medications called GLP-1 receptor agonists completely changed the landscape of obesity…
CVS Caremark, the largest pharmacy benefit manager in the United States, is reversing a controversial decision. The company cut off coverage for one of the country’s most prescribed obesity medications last year. Now, it is bringing that coverage back. Starting…
The weight-loss medicine market is facing a major shift today. A major pharmaceutical company secured federal approval for a new pill recently. Consequently, the Wegovy pill represents the first cleared oral option. Another competing firm secured approval for Foundayo shortly…
Eli Lilly introduced Foundayo as a highly anticipated oral medication. During its first week of broad market availability, the drug recorded exactly 1,390 prescriptions. Consequently, the following week yielded 3,707 total pharmacy orders. These early performance figures currently lag competing…
The national regulatory agency recently authorized a groundbreaking medication called Foundayo. This vital green light gives Eli Lilly a powerful new tool in the competitive weight management sector. Unlike previous treatments, Foundayo gives patients a simple oral option. Consequently, this…
The ACHIEVE-4 trial recently confirmed the safety of a new oral drug called Foundayo. This study monitored 2,700 patients to see how the medication affects the heart and liver. Eli Lilly reported that the results met all safety requirements set…